Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-n-(2,2-dimethylprpyl)-3-pyridinecarboxamide
2. Gsk-ahab
3. Gw856553
1. 585543-15-3
2. Gsk-ahab
3. Gw856553
4. Gw856553x
5. Gw-856553
6. Gskahab
7. 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-n-(2,2-dimethylpropyl)pyridine-3-carboxamide
8. F2dqf16bxe
9. Losmapimod (gw856553x)
10. Ftx1821
11. Ftx-1821
12. Gw-856553x
13. Gsk-ahab;gw856553x;sb856553
14. 6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-n-neopentylnicotinamide
15. 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-n-(2,2-dimethylpropyl)pyridine-3-carboxamide.
16. Losmapimod [usan:inn]
17. Unii-f2dqf16bxe
18. 3-pyridinecarboxamide, 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-n-(2,2-dimethylpropyl)-
19. 3-pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-n-(2,2-dimethylpropyl)-
20. Gw 856553x
21. Sb 856553
22. Losmapimod [inn]
23. Losmapimod (usan/inn)
24. Losmapimod [usan]
25. Losmapimod,gw-856553
26. Losmapimod [who-dd]
27. Gtpl7835
28. Schembl1070401
29. Chembl1088752
30. Dtxsid30974109
31. Ex-a486
32. Chebi:131167
33. Hms3653g19
34. Hms3673k13
35. Losmapimod Pound>>gw-856553
36. Bcp09909
37. Bdbm50418610
38. Mfcd16619322
39. Nsc785336
40. Nsc800785
41. S7215
42. Zinc35793138
43. Akos015994587
44. Ccg-268442
45. Cs-3235
46. Db12270
47. Ge-0056
48. Nsc-785336
49. Nsc-800785
50. Sb16761
51. Ncgc00386332-03
52. Ncgc00481552-01
53. Ac-35781
54. Da-33431
55. Gs856553
56. Hy-10402
57. Sb856553
58. Gw 856553
59. B4620
60. Ft-0700337
61. Sw219307-1
62. D09639
63. 543c153
64. Q6683687
65. 6-(5-cyclopropylcarbamoyl-3-fluoro-2-methyl-phenyl)-n-(2,2-dimethylpropyl)-nicotinamide
66. 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-n-(2,2-dimethylpropyl)nicotinamide
67. 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-n-(2,2-dimethylpropyl)-3-pyridinecarboxamide
| Molecular Weight | 383.5 g/mol |
|---|---|
| Molecular Formula | C22H26FN3O2 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 383.20090524 g/mol |
| Monoisotopic Mass | 383.20090524 g/mol |
| Topological Polar Surface Area | 71.1 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 573 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
71
PharmaCompass offers a list of Losmapimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Losmapimod manufacturer or Losmapimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Losmapimod manufacturer or Losmapimod supplier.
PharmaCompass also assists you with knowing the Losmapimod API Price utilized in the formulation of products. Losmapimod API Price is not always fixed or binding as the Losmapimod Price is obtained through a variety of data sources. The Losmapimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Losmapimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Losmapimod, including repackagers and relabelers. The FDA regulates Losmapimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Losmapimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Losmapimod supplier is an individual or a company that provides Losmapimod active pharmaceutical ingredient (API) or Losmapimod finished formulations upon request. The Losmapimod suppliers may include Losmapimod API manufacturers, exporters, distributors and traders.
Losmapimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Losmapimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Losmapimod GMP manufacturer or Losmapimod GMP API supplier for your needs.
A Losmapimod CoA (Certificate of Analysis) is a formal document that attests to Losmapimod's compliance with Losmapimod specifications and serves as a tool for batch-level quality control.
Losmapimod CoA mostly includes findings from lab analyses of a specific batch. For each Losmapimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Losmapimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Losmapimod EP), Losmapimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Losmapimod USP).
